Historically AMR clinical research centers have enrolled more than 145,600 subjects in 7,750 clinical trials. AMR’s extensive experience includes phase I-IV healthy volunteer trials, device trials, and disease-specific trials across a wide range of therapeutic areas. In 2020, AMR was awarded multiple COVID-19 Investigational Vaccine Trials including one of the first two Phase I studies completed in the United States.
The following list summarizes AMR’s primary areas of expertise:
- Cardiology/Cardiovascular/Cardiac Surgery
- Dermatology
- Devices/Diagnostics
- Endocrinology
- Gastroenterology
- General/Plastic Surgery
- Hematology/Oncology
- Immunological Solutions
- Infectious Diseases
- Men’s Health
- Musculoskeletal/Connective Tissue Disorders
- Neurology
- Nutrition Solutions
- Ophthalmology/Optometry
- Orthopedics
- Otolaryngology
- Pain/Nausea and/or Emesis Management
- Pediatrics
- Phase I/Healthy Volunteer
- Podiatry
- Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Smoking/Modified-Risk Tobacco Products
- Urology/Nephrology
- Vaccine Solutions
- Vascular/Vascular Surgery
- Virology
- Women’s Health